Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to IT000175priorityCriticalpatent/IT224813Z2/en
Publication of ITBO910175V0publicationCriticalpatent/ITBO910175V0/en
Publication of ITBO910175U1publicationCriticalpatent/ITBO910175U1/en
Application grantedgrantedCritical
Publication of IT224813Z2publicationCriticalpatent/IT224813Z2/en
Il secondo stadio del dispositivo erogatore d'aria per uso subacqueo prevede un organo di iniezione dell'aria comprendente un corpo tubolare chiuso a un'estremità da una vite di regolazione. All'interno di tale corpo tubolare è montato scorrevole un organo otturatore dì forma tubolare bilanciato rispetto alla pressione dell'aria e sollecitato assialmente da mezzi a molla agenti a riscontro di detto corpo tubolare, in modo da far tenuta frontalmente, a un'estremità, su detta vite di regolazione.The second stage of the air supply device for underwater use provides an air injection member comprising a tubular body closed at one end by an adjustment screw. Inside this tubular body a shutter member is mounted slidingly with a tubular shape balanced with respect to the air pressure and axially stressed by spring means acting on the said tubular body, so as to make it held frontally, at one end, on said adjustment screw.
IT0001751991-10-021991-10-02
SECOND STAGE OF THE WATER DISPENSER DEVICE FOR UNDERWATER USE
IT224813Z2
(en)
USE OF THE GM1 MONOSIALOGANGLIOSIDE OR N-DICLOROACETIL-LISO-GM1 TO PREVENT OR INVEST THE NEURONAL DEGENERATION INDUCED BY A LONG-DURATION TREATMENT WITH L-DOPA IN PARKINSON DISEASE THERAPY.